Tag: SGLT2 inhibitors
Heart Failure Medications: Monitoring Guide for Special Populations
Discover critical monitoring strategies for heart failure medications in special populations. Learn how age, gender, and ethnicity impact drug safety and efficacy.
SGLT2 Inhibitors and Diabetic Ketoacidosis: Serious Risk Overview
SGLT2 inhibitors like Jardiance and Farxiga carry a risk of euglycemic diabetic ketoacidosis (euDKA), a condition where DKA occurs with normal blood sugar levels. Learn the symptoms, triggers, and safety guidelines to prevent this serious complication.
SGLT2 Inhibitors for Type 2 Diabetes: Protecting Your Heart and Kidneys
Discover how SGLT2 inhibitors protect the heart and kidneys in Type 2 Diabetes patients. Learn about benefits, side effects, and the latest clinical trial data.